SPL 3.13% 9.9¢ starpharma holdings limited

Considering the company had boston consulting engaged to provide...

  1. WBA
    2,248 Posts.
    lightbulb Created with Sketch. 404
    Considering the company had boston consulting engaged to provide the to market strategy, you'd be amazed if they thought it could be marketed in USA without FDA approval....look what happened in UK and Aus, want another regulatory action?
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.9¢
Change
0.003(3.13%)
Mkt cap ! $40.82M
Open High Low Value Volume
9.8¢ 10.0¢ 9.7¢ $50.87K 510.1K

Buyers (Bids)

No. Vol. Price($)
1 180 9.8¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 101919 3
View Market Depth
Last trade - 15.20pm 05/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.